Transforming growth factor-β1 and vascular endothelial growth factor levels in senile acute myeloid leukemia and correlation with prognosis

Table 3 Correlations between clinical characteristics and vascular endothelial growth factor and transforming growth factor-β1 expression in patients with acute myeloid leukemia

Characteristic	Item	VEGF		χ2	P value	TGFβ1		χ2	P value
		Low	High			Low	High
Sex	Male	27	30	0.549	0.459	29	17	0.417	0.518
	Female	13	10			19	15
Age (yr)	< 60	23	29	0.244	0.622	21	22	1.427	0.232
	≥ 60	14	14			23	14
WBC (× 109/L)	< 10	14	26	6.054	0.014	28	11	8.673	0.003
	≥ 10	25	15			16	25
Hb (g/L)	< 80	25	16	5.031	0.025	16	23	6.004	0.014
	≥ 80	14	25			28	13
LDH (U/L)	< 250	13	11	1.164	0.281	21	9	2.507	0.113
	≥ 250	23	33			26	24
Plt (%)	< 80	13	28	7.155	0.007	18	7	4.246	0.039
	≥ 80	24	15			26	29

WBC: White blood cells; Hb: Hemoglobin; LDH: Lactate dehydrogenase; Plt: Platelet count; VEGF: Vascular endothelial growth factor; TGF-β1: Transforming growth factor-β1.